#LAAC
AF pt unsuitable for OAC? ASAP-TOO RCT of LAAC vs SAPT/no antithrombotic was underpowered due to poor accrual. No significant diff in ischemic stroke/systemic embolism. #LAAC overall low risk for complications.

More in the new LAAC focus issue of #JACC: https://bit.ly/4iJ8Mjr

#CardioSky #JACC
November 15, 2026 at 8:47 PM
Where does #LAAC fit in stroke prevention for pts w/ #AFib? New #JACC special issue brings together original research, randomized evidence, meta-analysis & expert perspectives examining LAAC vs. anticoagulation, pt selection, outcomes & more: https://bit.ly/4zaidyo

#CardioSky @bbikdeli.bsky.social
November 12, 2026 at 3:17 PM
Pour voir les œuvres d'Evelyne Axell, Dunkerque est "the place to be"... Jusqu'au 14 mars 2027 au LAAC.
November 15, 2026 at 9:45 PM
In OPTION, after #AFib ablation, left atrial appendage closure and oral anticoagulation had similar 36-month death, stroke, or embolism in both sexes. Bleeding fell more in men, driven by non-major bleeding (11.1% vs 3.9%).

Read more in the #LAAC issue of #JACC: https://bit.ly/4AjVwst
November 15, 2026 at 12:01 AM
How do we navigate decision about left #atrial #appendage #occlusion in #Afib?

honored to talk to @hmkyale.bsky.social RE @jaccjournals.bsky.social papers.

📹 here: youtu.be/8uy8wbnTEog

📝 here: jacc.org/doi/10.1016/j.jacc.2026.09.018

And the full issue here: jacc.org/special-collection/laac
November 14, 2026 at 5:12 PM
Dosis bajas de anticoagulantes orales directos y aspirina sola son no inferiores a la terapia antiplaquetaria dual a los 6m de un cierre no complicado del apéndice auricular izquierdo #LAAC #NOAC #aspirin #DAPT jamanetwork.com/journals/jam...
Antithrombotic Therapy After Left Atrial Appendage Occlusion
This randomized trial assesses whether reduced-dose non–vitamin K oral anticoagulants (NOACs) or aspirin alone are noninferior to dual antiplatelet therapy (DAPT) as antithrombotic therapy for the 6-m...
jamanetwork.com
November 16, 2026 at 10:02 AM
LAAC are as usefull as vena cava filters.

#Cardiosky
Reduced-dose #NOACs as well as aspirin alone were noninferior to #DAPT for a composite of adverse clinical outcomes through six months following LAAC, according to results from the SIMPLAAFY trial presented at #TCT2026.

Read more: https://bit.ly/4AdRF0h #CardioSky
November 2, 2026 at 7:51 PM
Late-Breaking Data at #TCT2026: The SIMPLAAFY post-implant drug regimen study showed that after WATCHMAN FLX™ Pro LAAC Device implant, aspirin alone and reduced dose NOAC were noninferior to DAPT.

View the data: qrco.de/bh4jKW
November 2, 2026 at 7:09 PM
Reduced-dose #NOACs as well as aspirin alone were noninferior to #DAPT for a composite of adverse clinical outcomes through six months following LAAC, according to results from the SIMPLAAFY trial presented at #TCT2026.

Read more: https://bit.ly/4AdRF0h #CardioSky
November 2, 2026 at 7:16 PM
【LAAC後の抗血栓療法はASA単剤がベスト?RCT “SIMPLAAFY”/JAMA】Nov.02

米国、LAACに成功の1.857例 [平均76歳] ランダム化——

・6カ月間の「死亡・脳卒中/塞栓症・大出血」発生率は、DPAT
 6.9%、減量DOAC 5.1%、アスピリン単剤 3.3%。
・ASAのみDAPTと有意差。
・DOAC、ASAともDAPTに非劣性。

全文🔗 qr.paps.jp/8GHwk
Antithrombotic Therapy After Left Atrial Appendage Occlusion
This randomized trial assesses whether reduced-dose non–vitamin K oral anticoagulants (NOACs) or aspirin alone are noninferior to dual antiplatelet therapy (DAPT) as antithrombotic therapy for the 6-m...
qr.paps.jp
November 3, 2026 at 1:53 AM
Great job! Two other compilations I can suggest:

- THE NET ADVANCE OF PHYSICS
web.mit.edu/redingtn/www...

- Educational Resources page of the LSC Academic Advisory Committee
wiki.ligo.org/LAAC/Educati...
The Net Advance of Physics
The Net Advance of Physics
web.mit.edu
November 1, 2026 at 9:41 PM
Musée d'art contemporain à #Dunkerque, #Nord. Le LAAC est né grâce au don à la ville de Dunkerque, d’un ensemble exceptionnel d’œ...
Suite 👉 https://monumentum.fr/musee-de-france/m0620/dunkerque-musee-dart-contemporain
October 30, 2026 at 5:49 PM
Transcatheter LAA closure vs OAC... similar adverse outcomes and still lots of strokes. Not profoundly practice changing as I wasn't routinely going for LAAC unless there was already a major adverse bleeding event. Good to have coalesced data #cardiosky #medsky pubmed.ncbi.nlm.nih.gov/42646743/
Catheter-Based Left Atrial Appendage Closure vs Oral Anticoagulation in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis - PubMed
In patients with AF, at long-term follow-up, transcatheter LAAC was associated with similar rates of any type of stroke and major bleeding compared with OAC, while increasing the risk of ischemic stro...
pubmed.ncbi.nlm.nih.gov
October 29, 2026 at 2:35 PM
If your patient asks for a left atrial appendage closure device, what should you tell them? On Beyond Journal Club from @coreimpodcast.bsky.social & NEJM Group, the hosts will help you understand the tradeoffs, build clinical judgment & learn from thoughtful counseling. 🎧 https://nej.md/4sxpczZ
October 30, 2026 at 1:00 PM
The primary results of the SIMPLAAFY randomized trial will be presented as Late Breaking Clinical data at #TCT2026. This trial evaluated two monotherapy regimens vs. DAPT after implant with WATCHMAN FLX™ Pro LAAC Device in patients with AF.

Learn more about SIMPLAAFY: qrco.de/bh3JTQ
October 20, 2026 at 1:30 PM
Dr. Rony Lahoud shows how the 3 radiopaque markers on the WATCHMAN FLX™ Pro LAAC Device support successful device placement. WATCHMAN FLX™ Pro is the only approved LAAC device with available RO markers to achieve clinically trusted seal. View the case.
October 15, 2026 at 5:00 PM
Among patients with #AtrialFibrillation, catheter-based #LeftAtrialAppendageClosure had similar overall stroke and major bleeding rates vs oral anticoagulation, but higher ischemic stroke risk and lower nonprocedural major bleeding. ja.ma/4hWSnHA
Catheter-Based LAAC vs OAC in Patients With AF
This systematic review and meta-analysis evaluates the efficacy and safety of catheter-based left atrial appendage closure compared to the gold standard of oral anticoagulation for patients with atrial fibrillation.
ja.ma
October 15, 2026 at 11:00 AM
Interested in how these findings fit into the broader evidence on LAAC?

Explore related studies through structured, visual Briefs on CurrentCardio:
currentcardio.com/explore/?q=L...
Explore · CurrentCardio
Explore CurrentCardio's archive of structured cardiology evidence: search by trial name, condition, intervention or outcome; narrow by topic, study design, journal and date; save a search or follow it...
currentcardio.com
October 15, 2026 at 2:27 PM
The Elite AF clinical trial is officially underway, marking an important step forward in LAAC innovation. This trial is designed to assess the safety and effectiveness of the next generation WATCHMAN Elite™ Left Atrial Appendage Closure Device.
October 13, 2026 at 1:00 PM
« Le voyage mystère c’est une question de confiance ! » : à Troyes, une agence vous emmène… sans vous dire où
➡️ https://l.leparisien.fr/lAAC
October 6, 2026 at 2:17 PM
CHAMPION-AF and CLOSURE-AF seemed to conflict on LAAC.

A new Europace review reconciles them: the benefit depends on the patient, not just the device.

• CHAMPION-like: lower bleeding risk, long life expectancy
• CLOSURE-like: frail, multimorbid, high competing mortality
October 5, 2026 at 6:06 PM
It's been a long time.
www.youtube.com/watch?v=lAac...
Wakey Wakey
YouTube video by Porcy
www.youtube.com
October 3, 2026 at 7:15 PM
A major bottleneck in growing #LAAC programs is ensuring that resources are smoothly managed during procedures. The latest MedAxiom white paper dives into how hospitals are tackling a common area of friction: imaging.

⏬Download the full white paper from MedAxiom: qrco.de/bh1Z4G
October 1, 2026 at 1:00 PM
Clinically Trusted Seal. Watch how WATCHMAN TruSteer™ Access System and WATCHMAN FLX™ Pro LAAC Device work together in harmony with mid-deploy steering to optimize appendage occlusion in this complex anatomy.

Proven Performance. Predictable Outcomes.
September 24, 2026 at 7:36 PM
Vacation inspiration: our 9 km hike up, down & around Laacher See near Mendig #Germany www.endlessmile.com/germany-laac...
September 21, 2026 at 9:31 AM